Ipamorelin and sermorelin Ipamorelin works by directly affecting the pituitary gland to stimulate growth hormone production
or discomfort from normal touch
Some compounding pharmacies and research sources list it as AOD-9604, AOD9604, or HGH Frag 176-191
Observational studies have associated higher circulating TMAO with cardiovascular risk, but those studies cannot prove cause and effect and often reflect broader dietary and microbial patterns
The following list outlines potential reactions: Mild discomfort, bruising, or redness at the injection site Temporary bloating or abdominal cramping (more common with IV drips) Allergic reactions, including rash or itching, in rare cases Potential kidney stress at very high, prolonged doses administered without medical supervision Possible interactions with chemotherapy drugs patients undergoing cancer treatment should consult their oncologist Serious adverse effects are typically associated with unregulated products, improper dosing, or administration in non-medical settings